JHBP CY HOLDINGS
JHBP CY Holdings is an investment holding company that engages in the research and development of oncology and autoimmune drugs.
JHBP CY HOLDINGS
Industry:
Biotechnology
Founded:
2007-12-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.genorbio.com
Status:
Active
Contact:
+86 21 61690700
Email Addresses:
[email protected]
Similar Organizations
BociMed
BociMed is a company engaged in drug research and development and clinical research.
Shaanxi Aierfu Tissue Engineering Company
Shaanxi Aierfu Tissue Engineering Company Limited engages in research and development of medical, biological and tissue engineering.
Official Site Inspections
http://www.genorbio.com
- Host name: 13.75.34.164
- IP address: 13.75.34.164
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "JHBP CY Holdings"
Genor Biopharma Co. Ltd | en
Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs. We have successfully developed drug candidates targeting pathways with blockbuster …See details»
genorbio.com Reviews: Is this site a scam or legit?
This term indicates whether genorbio.com has landed on any online directories' blacklists and earned a suspicious tag. Assessing HTTPS Connectivity. This section provides insight into …See details»
Genor Biopharma - Crunchbase Company Profile
Organization. Genor Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
嘉和生物药业有限公司 | 首页 - Genor Bio
嘉和生物药业（简称“嘉和生物”，股票代码：6998.hk）成立于2007年，是一家创新驱动型生物制药公司；目前已拥有强大的产品管线，涵盖全球前三大肿瘤靶标（乳腺癌、肺癌、胃肠道肿瘤）。See details»
Genor Biopharma Co. Ltd | About Genor
Founded in 2007, Genor Biopharma Co. Ltd. (Genor BioPharma, Stock code: 6998.HK) is an innovation-driven biopharma company with a pipeline of therapies covering the world's most prevalent cancer types (breast, lung, and …See details»
Genor BioPharma Co., Ltd. Management Team | Org Chart
Genorbio.com; Shuiqing Xu Director of Upstream Process Development at Genor BioPharma Co., Ltd. Shanghai, China View. View Similar People. Related Companies BioGrowing Probiotics. …See details»
Genor Biopharma Company Profile - Office Locations, Competitors …
Genor Biopharma has 2 employees at their 1 location and $212 m in total funding,. See insights on Genor Biopharma including office locations, competitors, revenue, financials, executives, …See details»
Genor Biopharma Company Profile | Management and Employees …
[email protected]: 3: first_last: [email protected]: 4: first: [email protected]: 5: last: [email protected]: Your Questions, Our Answers Get Free …See details»
Genor Biopharma Holdings Company Description - Stock Analysis
Mar 24, 2025 Company profile for Genor Biopharma Holdings Limited (HKG:6998) with a description, list of executives, contact details and other key facts.See details»
Genor Biopharma - Overview, News & Similar companies - ZoomInfo
Oct 7, 2020 Genor Biopharma contact info: Phone number: +86 2160690700 Website: www.genorbio.com What does Genor Biopharma do? Genor Biopharma is a pre-commercial …See details»
Genor Biopharma Co., Ltd. - Drug pipelines, Patents, Clinical trials ...
Www.genorbio.com. Holding Company | Subsidiary Company | 2007 | Shanghai Shi, China | 100-250 | www.genorbio.com. Last update 12 Feb 2025. Overview. Pipeline. Deal. Translational …See details»
Genor Biopharma - Products, Competitors, Financials, Employees ...
Oct 7, 2020 genorbio.com. Overview & Products; Financials; Founded Year 2007. Stage IPO | IPO. Total Raised $865.11M. Date of IPO 10/7/2020. Market Cap 1.12B. Stock Price 2.16. …See details»
Genor Biopharma Holdings Limited - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Genor Biopharma Holdings Limited of GEORGE TOWN, GRAND CAYMAN. Get the latest business …See details»
Genor BioPharma 2025 Company Profile: Stock Performance
Genor BioPharma General Information Description. Genor Biopharma Holdings Ltd is a commercial-ready biopharmaceutical company focusing on developing and commercializing …See details»
Genor Biopharma CEO and Key Executive Team | Craft.co
Genor Biopharma's Chairman, Chief Excutive Officer is Feng Guo. Other executives include Shuhua Han, Chief Scientific Officer; Li Tong, Chief Medical Officer and 1 others. See the full …See details»
Genor Biopharma Co. Ltd | Investor Relations
Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs. We have successfully developed drug …See details»
Genor Biopharma Co. Ltd | Our People
Our leadership team has more than 20 years of industry experience on average with proven track record and a well-balanced combination of expertise.See details»
Genor wins $440M+ cancer drug deal with Third Rock/Two River …
Aug 7, 2024 China’s Genor Biopharma Co. Ltd. agreed to out-license GB-261, its bispecific antibody candidate primarily targeting B-cell lymphomas, to TRC 2004 Inc., a U.S.-based …See details»
Genor Biopharma Releases Its Annual Results for 2021
Mar 31, 2022 The research and development of GB263T fully demonstrated the advantages of cross-team collaboration and helped to expand the organization’s international capabilities and …See details»
Genor Biopharma Releases Its Annual Results for 2020
Mar 24, 2021 Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing. NDA/BLA progress - GB226 (Geptanolimab) Priority Review for PTCL, …See details»